199 related articles for article (PubMed ID: 28225421)
1. Committee Opinion No. 691 Summary: Carrier Screening for Genetic Conditions.
Obstet Gynecol; 2017 Mar; 129(3):597-599. PubMed ID: 28225421
[TBL] [Abstract][Full Text] [Related]
2. Committee Opinion No. 691: Carrier Screening for Genetic Conditions.
Obstet Gynecol; 2017 Mar; 129(3):e41-e55. PubMed ID: 28225426
[TBL] [Abstract][Full Text] [Related]
3. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
[TBL] [Abstract][Full Text] [Related]
4. Cystic fibrosis carrier population screening in the primary care setting.
Loader S; Caldwell P; Kozyra A; Levenkron JC; Boehm CD; Kazazian HH; Rowley PT
Am J Hum Genet; 1996 Jul; 59(1):234-47. PubMed ID: 8659530
[TBL] [Abstract][Full Text] [Related]
5. Carrier screening for thalassemia and hemoglobinopathies in Canada.
Langlois S; Ford JC; Chitayat D; ;
J Obstet Gynaecol Can; 2008 Oct; 30(10):950-959. PubMed ID: 19038079
[TBL] [Abstract][Full Text] [Related]
6. Active cascade testing for carriers of cystic fibrosis gene.
Super M; Schwarz MJ; Malone G; Roberts T; Haworth A; Dermody G
BMJ; 1994 Jun; 308(6942):1462-7. PubMed ID: 8019278
[TBL] [Abstract][Full Text] [Related]
7. "Suddenly Having two Positive People who are Carriers is a Whole New Thing" - Experiences of Couples Both Identified as Carriers of Cystic Fibrosis Through a Population-Based Carrier Screening Program in Australia.
Ioannou L; Delatycki MB; Massie J; Hodgson J; Lewis S
J Genet Couns; 2015 Dec; 24(6):987-1000. PubMed ID: 25925605
[TBL] [Abstract][Full Text] [Related]
8. Acceptability of carrier screening for cystic fibrosis during pregnancy in a German population.
Jung U; Urner U; Grade K; Coutelle C
Hum Genet; 1994 Jul; 94(1):19-24. PubMed ID: 8034290
[TBL] [Abstract][Full Text] [Related]
9. Committee Opinion No. 690 Summary: Carrier Screening in the Age of Genomic Medicine.
Obstet Gynecol; 2017 Mar; 129(3):595-596. PubMed ID: 28225420
[TBL] [Abstract][Full Text] [Related]
10. Antenatal screening for cystic fibrosis: a trial of the couple model.
Livingstone J; Axton RA; Gilfillan A; Mennie M; Compton M; Liston WA; Calder AA; Gordon AJ; Brock DJ
BMJ; 1994 Jun; 308(6942):1459-62. PubMed ID: 8019277
[TBL] [Abstract][Full Text] [Related]
11. Ethical considerations in choosing a model for population-based cystic fibrosis carrier screening.
Modra LJ; Massie RJ; Delatycki MB
Med J Aust; 2010 Aug; 193(3):157-60. PubMed ID: 20678044
[TBL] [Abstract][Full Text] [Related]
12. Antenatal screening for carriers of cystic fibrosis: randomised trial of stepwise v couple screening.
Miedzybrodzka ZH; Hall MH; Mollison J; Templeton A; Russell IT; Dean JC; Kelly KF; Marteau TM; Haites NE
BMJ; 1995 Feb; 310(6976):353-7. PubMed ID: 7866213
[TBL] [Abstract][Full Text] [Related]
13. Prenatal genetic carrier testing using triple disease screening.
Eng CM; Schechter C; Robinowitz J; Fulop G; Burgert T; Levy B; Zinberg R; Desnick RJ
JAMA; 1997 Oct; 278(15):1268-72. PubMed ID: 9333269
[TBL] [Abstract][Full Text] [Related]
14. Expanded carrier screening for recessively inherited disorders: economic burden and factors in decision-making when one individual in a couple is identified as a carrier.
Shapiro AJ; Kroener L; Quinn MM
J Assist Reprod Genet; 2021 Apr; 38(4):957-963. PubMed ID: 33501564
[TBL] [Abstract][Full Text] [Related]
15. CFTR mutation screening in an assisted reproductive clinic.
Field PD; Martin NJ
Aust N Z J Obstet Gynaecol; 2011 Dec; 51(6):536-9. PubMed ID: 21875427
[TBL] [Abstract][Full Text] [Related]
16. Population-based carrier screening for cystic fibrosis in Victoria: the first three years experience.
Massie J; Petrou V; Forbes R; Curnow L; Ioannou L; Dusart D; Bankier A; Delatycki M
Aust N Z J Obstet Gynaecol; 2009 Oct; 49(5):484-9. PubMed ID: 19780730
[TBL] [Abstract][Full Text] [Related]
17. Genetic testing for cystic fibrosis.
Beaudet AL
Pediatr Clin North Am; 1992 Apr; 39(2):213-28. PubMed ID: 1553241
[TBL] [Abstract][Full Text] [Related]
18. Cystic fibrosis heterozygote screening in 5,161 pregnant women.
Witt DR; Schaefer C; Hallam P; Wi S; Blumberg B; Fishbach A; Holtzman J; Kornfeld S; Lee R; Nemzer L; Palmer R
Am J Hum Genet; 1996 Apr; 58(4):823-35. PubMed ID: 8644747
[TBL] [Abstract][Full Text] [Related]
19. CF carrier testing in a high risk population: anxiety, risk perceptions, and reproductive plans of carrier by "non-carrier" couples.
Callanan NP; Cheuvront BJ; Sorenson JR
Genet Med; 1999; 1(7):323-7. PubMed ID: 11263543
[TBL] [Abstract][Full Text] [Related]
20. Reporting the results of cystic fibrosis carrier screening.
Asch DA; Patton JP; Hershey JC; Mennuti MT
Am J Obstet Gynecol; 1993 Jan; 168(1 Pt 1):1-6. PubMed ID: 8420307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
